• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER® TORQVUE® LP DELIVERY SYSTEM; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER® TORQVUE® LP DELIVERY SYSTEM; CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Tricuspid Regurgitation (2112)
Event Date 09/19/2018
Event Type  Injury  
Manufacturer Narrative
An event of damage to the tricuspid valve was reported.A more comprehensive assessment could not be performed since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Reference manufacturing report 2135147-2020-00217.On (b)(6) 2018, a 5x2mm amplatzer duct occluder ii additional sizes was implanted in the pulmonary position.The patient was (b)(6) days old, (b)(6) grams on date of implant.The pda dimension was the following by echocardiography: minimal ductal diameter: 3mm, maximum ductal diameter: 3.9mm, length: 11.4mm, placement and initial echocardiogram revealed the device was well placed.On (b)(6) 2018, valve damage was observed with severe regurgitation and leaflet perforation of the tricuspid valve.On (b)(6) 2018, the device had migrated toward the pulmonary artery and was partly in mpa, with a large degree of left to right low velocity patent ductus.The patient was brought back to the cath lab and the occluder was explanted without any complications.On (b)(6) 2018, echocardiogram showed the pda had decreased in size and was almost not viewable.The patient is reported to be stable will continue to be monitored.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER® TORQVUE® LP DELIVERY SYSTEM
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key10073307
MDR Text Key191567674
Report Number2135147-2020-00217
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 05/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMPLATZER ADOII AS 5X2MM IDE LONG PKG ST
Patient Outcome(s) Required Intervention;
Patient Age76 DA
Patient Weight1
-
-